Venetia Christle Veigas

Ambitious and detail-oriented pharmaceutical graduate with a passion for drug development, formulation, and analysis. Strong foundation in analytical chemistry, bioanalysis, and GLP-regulated environments. Skilled in sample preparation, method development, validation, and high-precision instrumentation. Proven ability to improve laboratory efficiency, reduce errors, and contribute to high-impact pharmaceutical research. Excellent communicator and team player with proven organizational skills, thriving in high-pressure environments while managing multiple priorities. Committed to contributing to healthcare advancements through innovation, precision, and proactive problem-solving.

Stimuli-responsive hydrogel carrier for targeted colonic drug delivery, Queens University Belfast

• Developed an optimized stimuli-responsive hydrogel, achieving 30%+ higher drug release, 10% greater stability, and 30% less premature leakage. Gained expertise in polymer synthesis, characterization, and drug delivery optimization.
• Gained expertise on advanced characterization techniques, including DSC, TGA, ATR-FTIR, SEM, HPLC, polymer texture analysis, contact angle analysis, and cell culture assays (MTT assay).
• Reduced instrumental errors by 10% across all characterization techniques, ensuring data accuracy and maintaining ≥95% efficiency in experimental workflows. Developed expertise in quality control, precision analysis, and GLP compliance.
• Independently developed COSHH form for safe handling of chemicals, ensuring all safety protocols were meticulously followed. Ensured 100% accuracy in documentation and record-keeping for data traceability and reproducibility.

Effect of Beta-Caryophyllene in the prevention of renal damage in glycerol induced acute renal failure in Rats, MCOPS

• Conducted a preclinical study on 30+ rats to evaluate beta-caryophyllene's therapeutic effects on glycerol-induced renal failure, ensuring statistically significant results (p < 0.05).
• Administered treatments intramuscularly and orally with 95% dosing accuracy, ensuring precise drug absorption and animal handling.
• Assessed drug activity using UV spectroscopy, ELISA and chemical analysis, ensuring highly reproducible analytical chemistry results.
• Performed ANOVA-based statistical modeling, achieving 99% confidence in data interpretation.
• Optimized preclinical methodologies, improving research accuracy and enhancing scientific documentation.
  

• Future ready award, 2024 Queens University Belfast
• First place in the compounding event held at annual academic fest ‘Pharmaquora', 2020 MCOPS
• Sports representative, 2021 MCOP

• Level 7 Certificate in 'Strategic Management and Leadership Practice', 2024 CMI
• Molecule to Market Virtual Experience programme, 2023 Pfizer UK
• Drug Discovery & Drug Development, 2022 Coursera
• Global cancer consortium translational radiation oncology mini symposium, 2021 MCOPS
• Virtual training on ‘pharmaceutical techniques involved in drug design & analysis', 2021 MCOPS